Use of ARN-509 in Prostate Cancer

Special Reports, Genitourinary (Issue 2), Issue 2

Charles J. Ryan, MD, Professor of Clinical Medicine, Urology, Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), discusses the use of ARN-509 and its efficacy in treating prostate cancer.